Full Text
New all oral therapy for chronic hepatitis C virus (HCV)- A cost-benefit analysis

Abstract

Authors

J. Orsi M. Einodshofer H. Kirkham P. Glover J. DuChane

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×